These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24957587)
1. An unusual case of bowel perforation. Lazarescu RE; Bohm K BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957587 [TBL] [Abstract][Full Text] [Related]
2. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy]. Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368 [TBL] [Abstract][Full Text] [Related]
3. Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer: retrospective case series and literature review. Imbulgoda A; MacLean A; Heine J; Drolet S; Vickers MM Can J Surg; 2015 Jun; 58(3):167-71. PubMed ID: 25799132 [TBL] [Abstract][Full Text] [Related]
6. [A bowel perforation with metallic stent placement for advanced rectal cancer during bevacizumab-based chemotherapy]. Yoshinami T; Ichiba M; Hayashi S; Yamamoto K; Shibuya M; Higashimoto Y Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):625-31. PubMed ID: 20379097 [TBL] [Abstract][Full Text] [Related]
7. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery]. Abbrederis K; Kremer M; Schuhmacher C Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167 [TBL] [Abstract][Full Text] [Related]
8. Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases. Lecarpentier E; Ouaffi L; Mir O; Berveiller P; Maurel M; Pujade-Lauraine E; Bouillot JL; Veyrie N Invest New Drugs; 2011 Dec; 29(6):1500-3. PubMed ID: 20676743 [TBL] [Abstract][Full Text] [Related]
9. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management. Heinzerling JH; Huerta S Curr Surg; 2006; 63(5):334-7. PubMed ID: 16971205 [TBL] [Abstract][Full Text] [Related]
10. Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers. Abu-Hejleh T; Mezhir JJ; Goodheart MJ; Halfdanarson TR Curr Oncol Rep; 2012 Aug; 14(4):277-84. PubMed ID: 22532266 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal perforation in metastatic carcinoma: a complication of bevacizumab therapy. Collins D; Ridgway PF; Winter DC; Fennelly D; Evoy D Eur J Surg Oncol; 2009 Apr; 35(4):444-6. PubMed ID: 18417314 [No Abstract] [Full Text] [Related]
12. Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab? Richardson DL; Backes FJ; Hurt JD; Seamon LG; Copeland LJ; Fowler JM; Cohn DE; O'Malley DM Gynecol Oncol; 2010 Jul; 118(1):47-51. PubMed ID: 20382413 [TBL] [Abstract][Full Text] [Related]
13. A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer. del Carmen MG; Micha J; Small L; Street DG; Londhe A; McGowan T Gynecol Oncol; 2012 Sep; 126(3):369-74. PubMed ID: 22659190 [TBL] [Abstract][Full Text] [Related]
14. [A case of metachronous gastrointestinal perforation of a patient with metastatic rectal cancer during treatment with bevacizumab-based chemotherapy]. Sadatomo A; Koinuma K; Miki A; Horie H; Yasuda Y Gan To Kagaku Ryoho; 2013 Jul; 40(7):943-5. PubMed ID: 23863742 [TBL] [Abstract][Full Text] [Related]
15. Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated. Borzomati D; Nappo G; Valeri S; Vincenzi B; Ripetti V; Coppola R Updates Surg; 2013 Jun; 65(2):121-4. PubMed ID: 23532741 [TBL] [Abstract][Full Text] [Related]
16. Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients. Borofsky SE; Levine MS; Rubesin SE; Tanyi JL; Chu CS; Lev-Toaff AS Abdom Imaging; 2013 Apr; 38(2):265-72. PubMed ID: 22627832 [TBL] [Abstract][Full Text] [Related]
17. Bowel perforation in non-small cell lung cancer after bevacizumab therapy. Schellhaas E; Loddenkemper C; Schmittel A; Buhr HJ; Pohlen U Invest New Drugs; 2009 Apr; 27(2):184-7. PubMed ID: 18665327 [TBL] [Abstract][Full Text] [Related]
18. Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning? Fuccio L; Cennamo V Gastrointest Endosc; 2010 Dec; 72(6):1330; author reply 1330-2. PubMed ID: 21111886 [No Abstract] [Full Text] [Related]
19. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. Cannistra SA; Matulonis UA; Penson RT; Hambleton J; Dupont J; Mackey H; Douglas J; Burger RA; Armstrong D; Wenham R; McGuire W J Clin Oncol; 2007 Nov; 25(33):5180-6. PubMed ID: 18024865 [TBL] [Abstract][Full Text] [Related]
20. [Surgical management of bevacizumab-associated peritonitis due to perforation]. Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]